Hyperfine (NASDAQ:HYPR) Shares Down 6.8% – Time to Sell?

by · The Cerbat Gem

Hyperfine, Inc. (NASDAQ:HYPR – Get Free Report)’s share price fell 6.8% during mid-day trading on Monday . The stock traded as low as $0.9250 and last traded at $0.9277. 3,219,550 shares traded hands during mid-day trading, an increase of 501% from the average session volume of 536,113 shares. The stock had previously closed at $0.9959.

Wall Street Analysts Forecast Growth

HYPR has been the subject of a number of recent research reports. Wall Street Zen upgraded shares of Hyperfine from a “sell” rating to a “hold” rating in a research note on Saturday, October 25th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Hyperfine in a research report on Wednesday, October 8th. Two analysts have rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, Hyperfine currently has a consensus rating of “Hold” and an average price target of $1.28.

Read Our Latest Stock Analysis on HYPR

Hyperfine Price Performance

The firm has a market capitalization of $92.61 million, a P/E ratio of -1.83 and a beta of 1.08. The company’s 50 day moving average price is $1.19 and its 200 day moving average price is $1.13.

Hyperfine (NASDAQ:HYPR – Get Free Report) last announced its quarterly earnings data on Thursday, November 13th. The company reported ($0.11) EPS for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.01). The firm had revenue of $3.44 million during the quarter, compared to the consensus estimate of $3.51 million. Hyperfine had a negative net margin of 378.17% and a negative return on equity of 97.95%. On average, research analysts anticipate that Hyperfine, Inc. will post -0.57 EPS for the current fiscal year.

Hedge Funds Weigh In On Hyperfine

Several large investors have recently bought and sold shares of the business. EP Wealth Advisors LLC bought a new stake in shares of Hyperfine during the 1st quarter valued at $25,000. Tortoise Investment Management LLC bought a new position in shares of Hyperfine in the 3rd quarter worth $65,000. Finally, Vanguard Group Inc. grew its stake in shares of Hyperfine by 5.7% during the third quarter. Vanguard Group Inc. now owns 3,511,972 shares of the company’s stock worth $5,092,000 after purchasing an additional 190,136 shares during the period. 15.03% of the stock is currently owned by institutional investors and hedge funds.

About Hyperfine

(Get Free Report)

Hyperfine, Inc, a medical device company, provides magnetic resonance imaging (MRI) products in the United States. The company offers Swoop Portable MR imaging system, which offers portable brain neuroimaging; and support and technical assistance services. It serves ICU, comprehensive, and primary stroke accredited facilities through direct sales and distributors.

Featured Articles